DE3675996D1 - Mittel mit kontinuierlicher peptidfreisetzung. - Google Patents

Mittel mit kontinuierlicher peptidfreisetzung.

Info

Publication number
DE3675996D1
DE3675996D1 DE8686109446T DE3675996T DE3675996D1 DE 3675996 D1 DE3675996 D1 DE 3675996D1 DE 8686109446 T DE8686109446 T DE 8686109446T DE 3675996 T DE3675996 T DE 3675996T DE 3675996 D1 DE3675996 D1 DE 3675996D1
Authority
DE
Germany
Prior art keywords
medium
peptide release
continuous peptide
relates
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686109446T
Other languages
English (en)
Inventor
Susan Mancini Cady
Richard Fishbein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE3675996D1 publication Critical patent/DE3675996D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth-hormone releasing factors (GH-RF) (Somatoliberin)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Cephalosporin Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8686109446T 1985-07-29 1986-07-10 Mittel mit kontinuierlicher peptidfreisetzung. Expired - Fee Related DE3675996D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75970185A 1985-07-29 1985-07-29

Publications (1)

Publication Number Publication Date
DE3675996D1 true DE3675996D1 (de) 1991-01-17

Family

ID=25056640

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686109446T Expired - Fee Related DE3675996D1 (de) 1985-07-29 1986-07-10 Mittel mit kontinuierlicher peptidfreisetzung.

Country Status (16)

Country Link
EP (1) EP0211267B1 (de)
JP (1) JPH0764740B2 (de)
KR (1) KR900005902B1 (de)
AT (1) ATE58838T1 (de)
AU (1) AU587626B2 (de)
CA (1) CA1277596C (de)
DE (1) DE3675996D1 (de)
DK (1) DK167140B1 (de)
ES (1) ES8801878A1 (de)
FI (1) FI85812C (de)
GR (1) GR861984B (de)
IE (1) IE59276B1 (de)
IL (1) IL79134A (de)
NO (1) NO171396C (de)
NZ (1) NZ216882A (de)
ZA (1) ZA865628B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
EP0400051B1 (de) * 1988-01-28 1995-05-10 Polygen Holding Corporation Polypeptide mit hormonwachstumsbefreiender wirkung
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
US4964892A (en) * 1988-12-22 1990-10-23 Rohm And Haas Company Synergistic microbicidal combinations containing 2-N-octyl-3-isothiazolone and certain commercial biocides
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
CH679207A5 (de) * 1989-07-28 1992-01-15 Debiopharm Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
IE20100174A1 (en) * 2010-03-25 2012-02-29 Trinity College Dublin Transdermal administration of peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517513A (en) * 1943-02-27 1950-08-01 Vaernet Carl Pharmaceutical preparation for implantation
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US3872714A (en) * 1974-01-29 1975-03-25 Gen Signal Corp Method and apparatus for testing a valve
FR2371422A1 (fr) * 1976-11-23 1978-06-16 Wellcome Found Nouveaux peptides et medicament contenant ces substances
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
JPS57134412A (en) * 1981-02-12 1982-08-19 Unitika Ltd Biodegradable drug donor
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3413608A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPH0764740B2 (ja) 1995-07-12
CA1277596C (en) 1990-12-11
KR900005902B1 (ko) 1990-08-16
IL79134A0 (en) 1986-09-30
EP0211267B1 (de) 1990-12-05
IL79134A (en) 1991-06-10
AU587626B2 (en) 1989-08-24
DK167140B1 (da) 1993-09-06
AU6061986A (en) 1987-02-05
DK350286A (da) 1987-01-30
FI863078A0 (fi) 1986-07-28
FI863078A (fi) 1987-01-30
DK350286D0 (da) 1986-07-23
FI85812C (fi) 1992-06-10
EP0211267A2 (de) 1987-02-25
IE861993L (en) 1987-01-29
NZ216882A (en) 1988-05-30
NO863027D0 (no) 1986-07-28
FI85812B (fi) 1992-02-28
KR870000933A (ko) 1987-03-10
ES8801878A1 (es) 1988-03-16
IE59276B1 (en) 1994-02-09
EP0211267A3 (en) 1987-10-14
ES556762A0 (es) 1988-03-16
NO863027L (no) 1987-01-30
GR861984B (en) 1986-12-29
ZA865628B (en) 1987-03-25
NO171396B (no) 1992-11-30
JPS6229531A (ja) 1987-02-07
ATE58838T1 (de) 1990-12-15
NO171396C (no) 1993-03-10

Similar Documents

Publication Publication Date Title
EP0219076A3 (en) Sustained release composition
DK0871476T3 (da) Tørret blodfaktorpræparat indeholdende trehalose
FI873087A0 (fi) Desensiterande dentalkomposition.
BR8902337A (pt) Composicao oral
BR8902338A (pt) Composicao oral
NZ216355A (en) Lyophilised emulsion compositions easily reconstituted for parenteral administration
BR8501231A (pt) Composicao corante aperfeicoada
DE3675996D1 (de) Mittel mit kontinuierlicher peptidfreisetzung.
DE3675995D1 (de) Mittel mit kontinuierlicher freisetzung von phenylethanolaminderivaten.
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
DE3781017D1 (de) Cytotoxische zusammensetzung aus "killer"-zellen.
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
BR6500407U (pt) Composicao medicinal
RO92098A2 (ro) Compozitie aditiva

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US

8339 Ceased/non-payment of the annual fee